INTECH Investment Management’s Dianthus Therapeutics DNTH Stock Holding History

INTECH Investment Management’s Portfolio DNTH Stock Details DNTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$915K	Buy	9,387 +1,922	+26%	+$168K	0.01%	1075
2026 Q1	$626K	Buy	7,465 +1,464	+24%	+$84.8K	0.01%	1234
2025 Q4	$247K	Buy	+6,001	New	+$233K	﹤0.01%	1864
2025 Q3	–	Sell	-12,969	Closed	-$242K	–	2433
2025 Q2	$242K	Hold	12,969	–	–	﹤0.01%	1992
2025 Q1	$235K	Buy	12,969 +3,726	+40%	+$82.1K	﹤0.01%	2002
2024 Q4	$201K	Buy	+9,243	New	+$238K	﹤0.01%	2026

Other funds holding DNTH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

INTECH Investment Management's DNTH Position: Q2 2026 in Review

INTECH Investment Management increased its Dianthus Therapeutics (DNTH) stake by 26% in Q2 2026, buying an estimated $168K and bringing the position to 9,387 shares worth $915K. The position accounts for 0.01% of the portfolio, ranked #1075.

INTECH Investment Management first reported a position in DNTH in Q4 2024 and has held it in 6 quarters since. 270 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

INTECH Investment Management held 9,387 shares of Dianthus Therapeutics worth $915K as of Q2 2026.
INTECH Investment Management bought 1,922 Dianthus Therapeutics shares in Q2 2026, an estimated $168K.
Dianthus Therapeutics made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1075 holding.
INTECH Investment Management first reported a position in Dianthus Therapeutics in Q4 2024 and has held it in 6 quarters since.
270 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.